1. Home
  2. MDXH vs SKYX Comparison

MDXH vs SKYX Comparison

Compare MDXH & SKYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDXH
  • SKYX
  • Stock Information
  • Founded
  • MDXH 2003
  • SKYX 2004
  • Country
  • MDXH Belgium
  • SKYX United States
  • Employees
  • MDXH N/A
  • SKYX N/A
  • Industry
  • MDXH
  • SKYX Building Products
  • Sector
  • MDXH
  • SKYX Consumer Discretionary
  • Exchange
  • MDXH Nasdaq
  • SKYX Nasdaq
  • Market Cap
  • MDXH 84.6M
  • SKYX 99.2M
  • IPO Year
  • MDXH 2021
  • SKYX 2022
  • Fundamental
  • Price
  • MDXH $2.18
  • SKYX $1.06
  • Analyst Decision
  • MDXH Buy
  • SKYX Strong Buy
  • Analyst Count
  • MDXH 1
  • SKYX 2
  • Target Price
  • MDXH $6.00
  • SKYX $3.50
  • AVG Volume (30 Days)
  • MDXH 67.5K
  • SKYX 945.2K
  • Earning Date
  • MDXH 08-20-2025
  • SKYX 08-11-2025
  • Dividend Yield
  • MDXH N/A
  • SKYX N/A
  • EPS Growth
  • MDXH N/A
  • SKYX N/A
  • EPS
  • MDXH N/A
  • SKYX N/A
  • Revenue
  • MDXH $94,507,000.00
  • SKYX $87,412,993.00
  • Revenue This Year
  • MDXH $23.51
  • SKYX $18.90
  • Revenue Next Year
  • MDXH $17.68
  • SKYX $29.10
  • P/E Ratio
  • MDXH N/A
  • SKYX N/A
  • Revenue Growth
  • MDXH 25.46
  • SKYX 12.42
  • 52 Week Low
  • MDXH $1.35
  • SKYX $0.75
  • 52 Week High
  • MDXH $3.50
  • SKYX $2.14
  • Technical
  • Relative Strength Index (RSI)
  • MDXH 58.07
  • SKYX 34.97
  • Support Level
  • MDXH $2.13
  • SKYX $1.15
  • Resistance Level
  • MDXH $2.32
  • SKYX $1.30
  • Average True Range (ATR)
  • MDXH 0.12
  • SKYX 0.10
  • MACD
  • MDXH 0.01
  • SKYX -0.02
  • Stochastic Oscillator
  • MDXH 76.19
  • SKYX 10.84

About MDXH MDxHealth SA

MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.

About SKYX SKYX Platforms Corp.

SKYX Platforms Corp operates in the business of developing proprietary technology that enables a quick and safe installation of electrical fixtures, such as light fixtures and ceiling fans. Its technology consists of a weight-bearing, fixable socket and a revolving plug for conducting electric power and supporting an electrical appliance attached to a wall or ceiling. The socket is comprised of a nonconductive body that houses conductive rings connectable to an electric power supply through terminals in its side exterior. The plug is also comprised of a nonconductive body that houses corresponding conductive rings, attaches to the socket via a male post, and is capable of feeding electric power to an appliance. It generates its income from lighting and heating products sold in the USA.

Share on Social Networks: